Xencor to Present at Jefferies 2017 Global Healthcare Conference Read more about Xencor to Present at Jefferies 2017 Global Healthcare Conference
Xencor's Lead Drug Candidate, XmAb5871, Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease Read more about Xencor's Lead Drug Candidate, XmAb5871, Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease
Xencor Reports First Quarter 2017 Financial Results Read more about Xencor Reports First Quarter 2017 Financial Results
Xencor to Host First Quarter 2017 Financial Results Webcast and Conference Call on May 9, 2017 Read more about Xencor to Host First Quarter 2017 Financial Results Webcast and Conference Call on May 9, 2017
Xencor to Present at 42nd Annual Deutsche Bank Health Care Conference Read more about Xencor to Present at 42nd Annual Deutsche Bank Health Care Conference
Xencor Appoints Kevin Gorman, Ph.D., to its Board of Directors Read more about Xencor Appoints Kevin Gorman, Ph.D., to its Board of Directors
Xencor to Present at Oppenheimer 27th Annual Healthcare Conference Read more about Xencor to Present at Oppenheimer 27th Annual Healthcare Conference
Xencor Announces Bruce L.A. Carter, Ph.D., Chairman of the Board of Directors, Will Not Stand for Reelection to Board of Directors at 2017 Annual Meeting of Stockholders Read more about Xencor Announces Bruce L.A. Carter, Ph.D., Chairman of the Board of Directors, Will Not Stand for Reelection to Board of Directors at 2017 Annual Meeting of Stockholders
Xencor Presents Preclinical Data on Emerging Bispecific Antibody Candidates at American Association for Cancer Research (AACR) 2017 Annual Meeting Read more about Xencor Presents Preclinical Data on Emerging Bispecific Antibody Candidates at American Association for Cancer Research (AACR) 2017 Annual Meeting
Xencor Reports Fourth Quarter and Full Year 2016 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2016 Financial Results
